4//SEC Filing
Zankel Todd 4
Accession 0001140361-12-039087
CIK 0001070698other
Filed
Aug 30, 8:00 PM ET
Accepted
Aug 31, 4:28 PM ET
Size
5.5 KB
Accession
0001140361-12-039087
Insider Transaction Report
Form 4
Zankel Todd
Chief Scientific Officer
Transactions
- Sale
Common Stock
2012-08-29$5.01/sh−10,136$50,781→ 659,214 total
Footnotes (2)
- [F1]Transaction made pursuant to a Rule 10b5-1 trading plan executed on January 9, 2012.
- [F2]This transaction was executed in multiple trades at prices ranging from $5.00 to $5.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Raptor Pharmaceutical Corp
CIK 0001070698
Entity typeother
Related Parties
1- filerCIK 0001362490
Filing Metadata
- Form type
- 4
- Filed
- Aug 30, 8:00 PM ET
- Accepted
- Aug 31, 4:28 PM ET
- Size
- 5.5 KB